Quadrivio Group's Silver Economy Fund has acquired a majority stake in Biotec Italia, enhancing its presence in the thriving aesthetic and healthcare markets.
Target Information
The Silver Economy Fund, part of Quadrivio Group, has successfully acquired a majority stake in Biotec Italia, a company renowned for its innovative aesthetic care solutions. This acquisition marks a strategic expansion for Quadrivio Group into the thriving healthcare and wellness sector, which is increasingly sought after by investment entities due to rising consumer demand for aesthetic and health services.
Biotec Italia, headquartered in Italy, specializes in cutting-edge medical aesthetics, focusing on treatments and products designed to enhance skin health and beauty. The company has established a strong reputation for its commitment to quality and customer satisfaction, making it an attractive investment opportunity.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Italy
The healthcare and aesthetic sectors in Italy are experiencing significant growth, driven by an aging population and a growing interest in cosmetic enhancement. The Italian beauty and
Similar Deals
Silver Economy Fund → Medical International Research (Mir)
2025
Silver Economy Fund → Mir-Medical International Research
2025
Quadrivio Group → Mir (Medical International Research)
2025
Silver Economy Fund → MIR – Medical International Research
2025
Silver Economy Fund (Quadrivio)
invested in
Biotec Italia
in 2025
in a Buyout deal